Sam Gandy, M.D., Ph.D., of the Icahn School of Medicine at Mount Sinai is leading an international team of researchers working to reprogram skin cells into brain cells to gain a better understanding of Alzheimer’s disease (AD). As part of the consortium, Dr. Gandy is collaborating with Scott Noggle, Ph.D., the New York Stem Cell Foundation’s Charles Evans Senior Research Fellow for Alzheimer’s Disease and director of the NYSCF’s laboratory in Manhattan.

Dr. Gandy heads the Stem Cell Consortium funded by Cure Alzheimer’s Fund. The consortium consists of six institutions that plan to directly investigate, for the first time, brain cells in petri dishes from individual patients who have the common form of AD.

To read the full article from Medical Science News, click here.